Inventor
SCHALL THOMAS
US14 patents
⚠️ This page may combine multiple inventors who share the name “SCHALL THOMAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHEMOCENTRYX INC
11 patentsUS11045469B2Jun 29, 2021
Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies
CHEMOCENTRYX INC5 citations83
US7335653B2Feb 26, 2008
Bis-aryl sulfonamides
CHEMOCENTRYX INC9 citations83
US10792360B1Oct 6, 2020
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies
CHEMOCENTRYX INC6 citations82
US11324736B2May 10, 2022
Method of Treating Focal Segmental Glomerulosclerosis
CHEMOCENTRYX INC2 citations72
US11020394B2Jun 1, 2021
Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C—C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies
CHEMOCENTRYX INC1 citations72
US10973809B2Apr 13, 2021
Method of treating focal segmental glomerulosclerosis
CHEMOCENTRYX INC4 citations72
US12194032B2Jan 14, 2025
Method of treating focal segmental glomerulosclerosis
CHEMOCENTRYX INC0 citations62
US11883391B2Jan 30, 2024
Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies
CHEMOCENTRYX INC0 citations62
US7678891B2Mar 16, 2010
Antibodies that bind CCX-CKR2
CHEMOCENTRYX INC3 citations61
US7741519B2Jun 22, 2010
Bis-aryl sulfonamides
CHEMOCENTRYX INC0 citations51
US7649011B2Jan 19, 2010
Inhibitors of human tumor-expressed CCXCKR2
CHEMOCENTRYX INC0 citations38